Health Care & Hospital Law,
Government,
Civil Litigation
Feb. 28, 2022
National opioid deal ends appeal of California appeal
When this agreement was first discussed, Orange County, the City of Los Angeles and other government entities in California continued to fight for a much larger sum — $52 billion — in a bench trial in Orange County alleging fraudulent and negligent business practices.
Drug manufacturer Johnson & Johnson and three of the biggest pharmaceutical distributors in the country agreed on Friday to commit $26 billion to fight the opioid crisis in the United States as part of a multistate settlement. This resolves more than 4,000 claims in 52 states and territories, including the first government-initiated opioid court action in the nation, tried in Orange County Superior Court.
The deal involving distributor...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In
Enewsletter Sign-up
Related Content
Corporate, Bankruptcy
Bankruptcy experts want to weigh in against J&J’s ‘abuse’ of system
By Blaise Scemama
Government, Criminal
DAs back bill to make murder charge easier in fentanyl deaths
By Kamila Knaudt
Government, Criminal
Doctor acquitted of shipping unapproved anti-addiction drug
By Blaise Scemama
Bankruptcy
Legislation could end corporate bankruptcy forum shopping
By Blaise Scemama
Civil Litigation, Bankruptcy
Jones Day remains in J&J bankruptcy amid calls to end case
By Blaise Scemama
